2017 Vol.35, N°2 - Table of contents

March-April 2017

CME activity available for Italian physicians

The article "One Year in Review 2017: primary Sjögren’s syndrome" published in this current issue is also available as an online CME course. The course has been granted 5 (five) CME credits.

The registration and fruition of the online course is free of charge, the fee of EURO 25.00 (=20.49 + VAT) must be paid in order to obtain the credits.

This activity is valid for credit from May 15, 2017 through May 14, 2018.

Click here for more information on the CME activity.

purchase complete issue

One year in review

CER10335
2017,35,2
Pg. 0179-0191

Free to view

One year in review 2017: primary Sjögren’s syndrome
F. Ferro, E. Marcucci, M. Orlandi, C. Baldini, E. Bartoloni-Bocci

This article is also available as an online CME course. The course has been granted 5 (five) CME credits.

The registration and fruition of the online course is free of charge, the fee of EURO 25.00 (=20.49 + VAT) must be paid in order to obtain the credits.

This activity is valid for credit from May 15, 2017 through May 14, 2018.

Click here for more information on the CME activity.

Full Papers

CER9242
2017,35,2
Pg. 0192-0200

Free to view

Treat-to-target biologic therapy in patients with rheumatoid arthritis is more efficacious and safe compared to delayed initiation of biologics: a real-world study
C.E. Lampropoulos, P. Orfanos, M.N. Manoussakis, A.G. Tzioufas, H.M. Moutsopoulos, P.G. Vlachoyiannopoulos

CER9324
2017,35,2
Pg. 0201-0208

Free to view

Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study
O. Addimanda, M. Marino, I. Farina, M. Trevisani, E. Arrigoni, F. Lumetti, F. Crescentini, P. Sambo, A. Bezzi, M. Bruschi, D. Santilli, M. Reta, S. Bosi, G. Delsante, F. Girelli, L. Montaguti, R. Meliconi, M. Sebastiani, C. Ferri, N. Malavolta, M. Govoni, S. Trombetti, R. De Palma, C. Salvarani

CER9489
2017,35,2
Pg. 0209-0213

Free to view

Flare in axial spondyloarthritis: investigation of meaningful changes in symptomatic outcome measures
M. Dougados, E. Wood, L. Gossec, D. Van Der Heijde, I. Logeart

CER9385
2017,35,2
Pg. 0214-0220

Free to view

A national survey on the management of psoriatic arthritis using the Delphi method
E. Lubrano, F. Cantini, A. Mathieu, I. Olivieri, C. Salvarani, R. Scarpa, A. Marchesoni

CER9639
2017,35,2
Pg. 0221-0228

Free to view

Necessity of TNF-alpha inhibitor discontinuation in rheumatoid arthritis is predicted by smoking and number of previously used biological DMARDs
B.V. Cuppen, J.W. Jacobs, E.-J. Ter Borg, A.C. Marijnissen, J.W. Bijlsma, F.P. Lafeber, J.M. Van Laar
on behalf of all SRU investigators.

CER9325
2017,35,2
Pg. 0229-0233

Free to view

Genetic diagnostic profiling in axial spondyloarthritis: a real world study.
G.P. Thomas, D. Willner, P.C. Robinson, A. Cortes, R. Duan, M. Rudwaleit, N. Akkoc, J. Braun, C.-T. Chou, W.P. Maksymowych, S. Ozgocmen, E. Roussou, J. Sieper, R. Valle-Oñate, D. Van Der Heijde, J. Wei, P. Leo, M.A. Brown
and the International Genetics of Ankylosing Spondylitis Consortium

CER9522
2017,35,2
Pg. 0234-0240

Free to view

Predictive significance of CCL21 and CXCL13 levels in the minor salivary glands of patients with Sjögren’s syndrome
K.-E. Lee, J.-H. Kang, Y.-R. Yim, J.-E. Kim, J.-W. Lee, L. Wen, D.-J. Park, T.-J. Kim, Y.-W. Park, K.C. Yoon, J.S. Lee, S.-S. Lee

CER9463
2017,35,2
Pg. 0241-0246

Free to view

Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis
A. Giollo, O. Viapiana, A. Carletto, R. Ortolani, D. Biasi, D. Gatti, S. Adami, M. Rossini

CER9493
2017,35,2
Pg. 0247-0254

Free to view

DNA damage increase in peripheral neutrophils from patients with rheumatoid arthritis is associated with the disease activity and the presence of shared epitope
G. Martelli-Palomino, A.B. Paoliello-Paschoalato, J.C. Crispim, D.M. Rassi, R.D. Oliveira, P. Louzada, Y.M. Lucisano-Valim, E.A. Donadi

CER9676
2017,35,2
Pg. 0255-0261

Free to view

Physical fatigue characterises patient experience of primary Sjögren’s syndrome
S. Arends, P.M. Meiners, R.V. Moerman, F.G. Kroese, E. Brouwer, F.K. Spijkervet, A. Vissink, H. Bootsma

CER9478
2017,35,2
Pg. 0262-0269

Free to view

Comparing diffusion weighted imaging with clinical and blood parameters, and with short tau inversion recovery sequence in detecting spinal and sacroiliac joint inflammation in axial spondyloarthritis
H.Y. Chung, X. Xu, V.W.H. Lau, G. Ho, K.L. Lee, P.H. Li, H.H.L. Tsang, S.K. Kwok, C.S. Lau, C.S. Wong

CER9497
2017,35,2
Pg. 0270-0276

Free to view

Clinical and genetic associations of radiographic sacroiliitis and its different patterns in psoriatic arthritis
M. Haroon, R. Winchester, J.T. Giles, E. Heffernan, O. Fitzgerald

CER9698
2017,35,2
Pg. 0277-0287

Free to view

Increased mortality of incident rheumatoid arthritis versus matched non-RA control subjects: a community-based long-term prospective cohort study
A.T. Masi, A.A. Rehman, L.C. Jorgenson, J.C. Aldag

CER9553
2017,35,2
Pg. 0288-0295

Free to view

Comparable therapeutic potential of umbilical cord mesenchymal stem cells in collagen-induced arthritis to TNF inhibitor or anti-CD20 treatment
Y. Sun, W. Kong, S. Huang, B. Shi, H. Zhang, W. Chen, H. Zhang, C. Zhao, X. Tang, G. Yao, X. Feng, L. Sun

CER9568
2017,35,2
Pg. 0296-0302

Free to view

Management of dyslipidaemia in high-risk patients with recent-onset rheumatoid arthritis: targets still not met despite specific recommendations. Results from the ESPOIR cohort during the first five years of follow-up
A. Tournadre, B. Pereira, J.-J. Dubost, N. Rincheval, A.C. Rat, B. Combe, M. Soubrier

CER9657
2017,35,2
Pg. 0303-0308

Free to view

Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options
M. Fredi, F. Bartoli, I. Cavazzana, A. Ceribelli, N. Carabellese, A. Tincani, M. Satoh, F. Franceschini

Brief Papers

CER9004
2017,35,2
Pg. 0309-0312

Free to view

Circulating carotenoids and subsequent risk of rheumatoid arthritis in women
Y. Hu, J. Cui, J.A. Sparks, S. Malspeis, K.H. Costenbader, E.W. Karlson, B. Lu

CER9393
2017,35,2
Pg. 0313-0316

Free to view

Assessment of semaphorin 3A and its role in bone remodelling in a group of ankylosing spondylitis patients
F.M. Perrotta, F. Ceccarelli, C. Barbati, T. Colasanti, M. Montepaone, C. Alessandri, G. Valesini, E. Lubrano

CER9609
2017,35,2
Pg. 0317-0320

Free to view

Abatacept treatment of patients with primary Sjögren’s syndrome results in a decrease of germinal centres in salivary gland tissue
E.A. Haacke, B. Van Der Vegt, P.M. Meiners, A. Vissink, F.K. Spijkervet, H. Bootsma, F.G. Kroese

History of Medicine

CER9480
2017,35,2
Pg. 0321-0326

Free to view

On the history of gout: paleopathological evidence from the Medici family of Florence
V. Giuffra, S. Minozzi, A. Vitiello, A. Fornaciari

Case Reports

CER9808
2017,35,2
Pg. 0327-0329

Free to view

Evolving spectrum of LRBA deficiency-associated chronic arthritis: is there a causative role in juvenile idiopathic arthritis?
S.M. Al-Mayouf, H. Naji, K. Alismail, A.M. Alazami, F. Sheikh, W. Conca, H. Al-Mousa

Review

CER9588
2017,35,2
Pg. 0330-0336

Free to view

The role and diagnostic value of cell-free DNA in systemic lupus erythematosus
A. Truszewska, B. Foroncewicz, L. Pączek

CER9563
2017,35,2
Pg. 0337-0343

Free to view

TNF inhibitors increase fat mass in inflammatory rheumatic disease: a systematic review with meta-analysis
S. Marouen, T. Barnetche, B. Combe, J. Morel, C.I. Daïen

Paediatric Rheumatology

CER9873
2017,35,2
Pg. 0344-0500

Free to view

Myocardial performance index in active and inactive paediatric systemic lupus erythematosus
A. Khositseth, W. Prangwatanagul, K. Tangnararatchakit, S. Vilaiyuk, N. Su-Angka

Letters to the Editor

CER9961
2017,35,2
Pg. 0351

Free to view

Anti-carbonic anhydrase autoantibodies and serum beta-2 microglobulin correlate with the ClinESSDAI score in patients with Sjögren's syndrome
M. Pertovaara, S. Parkkila, M. Korpela

CER9401
2017,35,2
Pg. 0352

Free to view

Profile of initial drug therapy in paediatric systemic lupus erythematosus in Finland, 2000-2007
P. Elfving, K. Puolakka, H. Kautiainen, L.J. Virta, T. Pohjolainen, O. Kaipiainen- seppänen

CER10082
2017,35,2
Pg. 0353

Free to view

Transfusion-related acute lung injury in a patient with systemic lupus erythematosus
E. Pelechas, N. Gerolymatou, P.V. Voulgari, A.A. Drosos

CER10024
2017,35,2
Pg. 0354-0355

Free to view

Enhanced gut homing receptor expression of unswitched memory B cells in rheumatoid arthritis.
Y. Nagafuchi, H. Shoda, S. Sumitomo, S. Nakachi, R. Kato, Y. Tsuchida, H. Tsuchiya, K. Sakurai, N. Hanata, S. Tateishi, H. Kanda, K. Fujio, K. Yamamoto

CER9724
2017,35,2
Pg. 0356-0357

Free to view

A case report of neurosarcoidosis successfully treated with an infliximab biosimilar after a relapse while on dual therapy
D. Merinopoulos, F. Hayes, D.A. Gallagher, B. Dasgupta